Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Sigma Pharmaceuticals Limited - Strategy and SWOT Report

Sigma Pharmaceuticals Limited - Strategy and SWOT Report - new company profile report published


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2012-09-03 10:10:07 - Sigma Pharmaceuticals Limited - Strategy and SWOT Report - a new company profile report on companiesandmarkets.com

Sigma Pharmaceuticals Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the companys structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on Sigma Pharmaceuticals Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sigma Pharmaceuticals Limited in the form of a SWOT analysis
- An in-depth view of the business model of Sigma Pharmaceuticals Limited including a breakdown and examination of key business segments
- Intelligence on Sigma Pharmaceuticals Limiteds mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sigma Pharmaceuticals

 

 

Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Sigma Pharmaceuticals (Sigma) is a leading wholesaler and distributor of pharmaceutical products in Australia. The company also operates in New Zealand and Hong Kong. It is headquartered in Rowville, Victoria, Australia. The company recorded revenues of A$2,914.3 million ($2,700.4 million*) from its continuing operation in the financial year ended January 2011 (FY2011), an increase of 6.6% over FY2010. The companys operating profit was A$60.3 million ($55.9 million*) in FY2011, a decrease of 11.7% compared with FY2010. The net loss was A$235.4 million ($218.1 million*) in FY2011 as compared to a net loss of A$398.3 million ($369.1 million*) in FY2010. *Calculated using the constant conversion rate of A$1 = $0.9266 for the financial year ended January 31, 2011.

Reasons to Purchase:

- Gain understanding of Sigma Pharmaceuticals Limited and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Sigma Pharmaceuticals Limited as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers businesses better
- Stay up to date on Sigma Pharmaceuticals Limiteds business structure, strategy and prospects

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser